Breaking News

Astellas, Daiichi Form Compound Library Partnership

By Kristin Brooks | March 19, 2014

Will utilize each other's assets to foster open innovation

Astellas Pharma Inc. and Daiichi Sankyo Co., Ltd. are collaborating to form a compound library sharing partnership for approximately 400,000 selected compounds, in an effort to promote innovative R&D. The two companies will have access to the compound libraries that form the basis of their drug discovery research, and through High Throughput Screening (HTS), the companies can search for potentially beneficial compounds to develop new drugs. For a period of three years, both companies will be able to implement broad HTS using the shared compounds without restrictions on targeted disease areas. If one company identifies a candidate compound for development, the receiving company may develop and commercialize the new drug for any indication for human diseases.

blog comments powered by Disqus
  • Cold Chain Packaging Trends

    Cold Chain Packaging Trends

    Kristin Brooks, Contract Pharma||February 4, 2016
    Susan Li of UPS discusses supply chain trends, challenges, and packaging innovations

  • Packaging Equipment Trends Preview

    Packaging Equipment Trends Preview

    Kristin Brooks, Contract Pharma||January 26, 2016
    Christian Treitel of Bosch Packaging Technology discusses trends and capabilities

  • Tackling Drug Serialization Challenges

    Tackling Drug Serialization Challenges

    Tim Wright, editor||January 22, 2016
    Siemens and Adents together will develop a combined hardware plus software solution for pharma industry

  • CMC Biologics: Growing Through Innovation

    Tim Wright, Editor||January 28, 2016
    The new chief exec talks about industry trends and growth plans.

  • Cold-Chain Logistics & The Central Lab

    Kristin Brooks, Associate Editor||January 28, 2016
    Eric Hayashi of LabConnect discusses safety measures to ensure sample integrity

  • A Look at DCAT Week ‘16

    Tim Wright, Editor||January 28, 2016
    On the pulse of the pharmaceutical manufacturing value chain, DCAT Week ‘16 will deliver top-flight education programs and networking events.